Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Geneus
company
About
Geneus is a developer of gene sequencers and reagents.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Biotechnology
- Founded date
- Apr 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Geneus has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2021 | Series B | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Geneus is funded by 2 investors.
Darun Touzi
and Rays Venture Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Rays Venture Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
